Abstract |
|
Authors | Irina Crismaru, Anca Pantea Stoian, Ovidiu Gabriel Bratu, Mihnea-Alexandru Gaman, Ana Maria Alexandra Stanescu, Nicolae Bacalbasa, Camelia Cristina Diaconu |
Journal | Lipids in health and disease
(Lipids Health Dis)
Vol. 19
Issue 1
Pg. 85
(May 06 2020)
ISSN: 1476-511X [Electronic] England |
PMID | 32375792
(Publication Type: Journal Article, Review)
|
Chemical References |
- ALN-PCS
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents
- BMS201038
- Benzimidazoles
- Bile Acids and Salts
- Carrier Proteins
- Cholesterol, LDL
- Dicarboxylic Acids
- Fatty Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- PCSK9 Inhibitors
- RNA, Small Interfering
- microsomal triglyceride transfer protein
- 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
- PCSK9 protein, human
- Proprotein Convertase 9
- Ezetimibe
- evolocumab
- alirocumab
|
Topics |
- Antibodies, Monoclonal, Humanized
(therapeutic use)
- Anticholesteremic Agents
(therapeutic use)
- Atherosclerosis
(genetics, metabolism, pathology, prevention & control)
- Benzimidazoles
(therapeutic use)
- Bile Acids and Salts
(antagonists & inhibitors, metabolism)
- Carrier Proteins
(antagonists & inhibitors, genetics, metabolism)
- Cholesterol, LDL
(antagonists & inhibitors, metabolism)
- Dicarboxylic Acids
(therapeutic use)
- Europe
- Ezetimibe
(therapeutic use)
- Fatty Acids
(therapeutic use)
- Gene Expression
- Guidelines as Topic
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(therapeutic use)
- Hypercholesterolemia
(drug therapy, genetics, metabolism, pathology)
- PCSK9 Inhibitors
- Proprotein Convertase 9
(genetics, metabolism)
- RNA, Small Interfering
(therapeutic use)
|